Gemini Therapeutics logo
Gemini Therapeutics GMTX
$ 1.56 0.97%

Quarterly report 2024-Q3
added 11-12-2024

report update icon

Gemini Therapeutics ROE Ratio 2011-2024 | GMTX

Annual ROE Ratio Gemini Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-22.15 -26.52 56.02 - - - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
56.02 -26.52 2.45

Quarterly ROE Ratio Gemini Therapeutics

2024-Q3 2024-Q2 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
-18.94 -17.55 -18.01 -1.62 18.7 34.57 41.34 28.17 -1.39 -23.4 -34.73 11.03 69.96 111.37 121.32 121.32 75.56 44.58 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
121.32 -34.73 31.24